Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type

The World Health Organization (WHO) classification recognizes 2 main categories of natural killer (NK) cell-derived neoplasms, namely, extranodal NK/T-cell lymphoma, nasal type, and aggressive NK-cell leukaemia. Extranodal nasal NK/T-cell lymphoma is more frequent in the Far East and Latin America....

Full description

Saved in:
Bibliographic Details
Main Authors: Harinder Gill, Raymond H. S. Liang, Eric Tse
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Advances in Hematology
Online Access:http://dx.doi.org/10.1155/2010/627401
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849467525277941760
author Harinder Gill
Raymond H. S. Liang
Eric Tse
author_facet Harinder Gill
Raymond H. S. Liang
Eric Tse
author_sort Harinder Gill
collection DOAJ
description The World Health Organization (WHO) classification recognizes 2 main categories of natural killer (NK) cell-derived neoplasms, namely, extranodal NK/T-cell lymphoma, nasal type, and aggressive NK-cell leukaemia. Extranodal nasal NK/T-cell lymphoma is more frequent in the Far East and Latin America. Histopathological and immunophenotypical hallmarks include angiocentricity, angiodestruction, expression of cytoplasmic CD3 epsilon (ε), CD56, and cytotoxic molecules and evidence of Epstein-Barr virus (EBV) infection. Early stage disease, in particular for localized lesion in the nasal region, is treated with chemotherapy and involved-field radiotherapy. On the other hand, multiagent chemotherapy is the mainstay of treatment for advanced or disseminated disease. L-asparaginase-containing regimens have shown promise in treating this condition. The role of autologous hematopoietic stem cell transplantation is yet to be clearly defined. Allogeneic hematopoietic stem cell transplantation, with the putative graft-versus-lymphoma effect, offers a potentially curative option in patients with advanced disease.
format Article
id doaj-art-e6f0dc86fcd247b49b6c78167a5afbcf
institution Kabale University
issn 1687-9104
1687-9112
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Advances in Hematology
spelling doaj-art-e6f0dc86fcd247b49b6c78167a5afbcf2025-08-20T03:26:10ZengWileyAdvances in Hematology1687-91041687-91122010-01-01201010.1155/2010/627401627401Extranodal Natural-Killer/T-Cell Lymphoma, Nasal TypeHarinder Gill0Raymond H. S. Liang1Eric Tse2Division of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong KongDivision of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong KongDivision of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong KongThe World Health Organization (WHO) classification recognizes 2 main categories of natural killer (NK) cell-derived neoplasms, namely, extranodal NK/T-cell lymphoma, nasal type, and aggressive NK-cell leukaemia. Extranodal nasal NK/T-cell lymphoma is more frequent in the Far East and Latin America. Histopathological and immunophenotypical hallmarks include angiocentricity, angiodestruction, expression of cytoplasmic CD3 epsilon (ε), CD56, and cytotoxic molecules and evidence of Epstein-Barr virus (EBV) infection. Early stage disease, in particular for localized lesion in the nasal region, is treated with chemotherapy and involved-field radiotherapy. On the other hand, multiagent chemotherapy is the mainstay of treatment for advanced or disseminated disease. L-asparaginase-containing regimens have shown promise in treating this condition. The role of autologous hematopoietic stem cell transplantation is yet to be clearly defined. Allogeneic hematopoietic stem cell transplantation, with the putative graft-versus-lymphoma effect, offers a potentially curative option in patients with advanced disease.http://dx.doi.org/10.1155/2010/627401
spellingShingle Harinder Gill
Raymond H. S. Liang
Eric Tse
Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
Advances in Hematology
title Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
title_full Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
title_fullStr Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
title_full_unstemmed Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
title_short Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
title_sort extranodal natural killer t cell lymphoma nasal type
url http://dx.doi.org/10.1155/2010/627401
work_keys_str_mv AT harindergill extranodalnaturalkillertcelllymphomanasaltype
AT raymondhsliang extranodalnaturalkillertcelllymphomanasaltype
AT erictse extranodalnaturalkillertcelllymphomanasaltype